Spots Global Cancer Trial Database for prx302
Every month we try and update this database with for prx302 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer | NCT03081481 | Prostate Cancer | PRX302 | 40 Years - | Sophiris Bio Corp | |
An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy | NCT00686088 | Locally Recurre... | PRX302 | 18 Years - | Protox Inc. | |
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer | NCT03081481 | Prostate Cancer | PRX302 | 40 Years - | Sophiris Bio Corp |